In August, manufacturer Eli Lilly responded by offering Zepbound vials in 2.5 milligram and 5 milligram dosage strengths ...

It is made possible through a first-of-a-kind integration with Eli Lilly’s direct-to-consumer website, and aims to streamline ...

A preliminary study on popular weight loss drugs finds participants shed more weight on Zepbound than on Novo Nordisk’s ...

(CNN) — Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from drugmaker Eli Lilly. (CNN) — Adults taking Zepbound lost 47% more ...

People taking Zepbound lost 20.2% of their body weight ... Patients received weekly injections of either drug, up to the maximum tolerated dose. The release of the results comes after both Lilly ...

That's according to new data from drug savings company GoodRx, which examined fill trends and spending patterns for weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound.

Eli Lilly, opens new tab said on Wednesday patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's (NOVOb.CO), opens new tab Wegovy in the first ...

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly. Photo by Pixabay/Pexels Zepbound, the new GLP-1 ...

Adults who take Zepbound lose more weight than those who take competitor weight loss drug Wegovy, according to new clinical trial results. Zepound manufacturer Eli Lilly released results from ...

With more people taking the weight-loss drugs Wegovy and Zepbound, one question inevitably arises: which one is more effective? In a press release, Lilly announced that in its latest trial ...

Shelby Knowles / Bloomberg / Getty Images Patients taking Eli Lilly's Zepbound lost more weight on average than those on Novo Nordisk's Wegovy in a new clinical study. Zepbound patients lost an ...